Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-08

FDA Approved: ATOMOXETINE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals’ supplemental application for atomoxetine, enabling a generic product. Atomoxetine is used to treat attention deficit hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atomoxetine (Atomoxetine)

Snippet

SUPPL AP for ATOMOXETINE (ATOMOXETINE)